Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 6/20 | 0.52 |
| ▸ | CA2 | P00918 | 5/20 | 0.52 |
| ▸ | APLNR | P35414 | 2/20 | 0.52 |
| ▸ | CA7 | P43166 | 3/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | LOXL2 | Q9Y4K0 | 3/20 | 0.34 |
| ▸ | LOX | P28300 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | CA5A | P35218 | 1/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1648801 | 1.00 | CA1 (0.52) | CA1CA2APLNRCA7CA12 | |
| SCHEMBL19479300 | 1.00 | CA1 (0.52) | CA1CA2APLNRCA7CA12 | |
| SCHEMBL21943788 | 1.00 | CA1 (0.52) | CA1CA2APLNRCA7CA12 | |
| SCHEMBL1649129 | 1.00 | CA1 (0.52) | CA1CA2APLNRCA7CA12 | |
| SCHEMBL19066054 | 1.00 | CA1 (0.52) | CA1CA2APLNRCA7CA12 | |
| SCHEMBL14462832 | 1.00 | CA1 (0.52) | CA1CA2APLNRCA7CA12 | |
| Hydrochloric Acid SCHEMBL21598754 | 0.97 | CA1 (0.50) | CA1CA2APLNRCA7CA12 | |
| SCHEMBL244348 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL29086421 | 0.94 | APLNR (0.52) | CA1CA2APLNRCA7CA12 | |
| SCHEMBL636980 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1428 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4301736-B1 | MACROCYCLIC COMPOUNDS AS PROTEASOME SUBUNIT BETA TYPE-5 INHIBITORS | LEAD DISCOVERY CENTER GMBH (DE) | 2025-10-08 | — | — | EP | claimed |
| EP-3917907-B1 | MODULATORS OF POTASSIUM ION CHANNELS AND USES THEREOF | UNIV DEGLI STUDI DI SALERNO (IT) | 2025-05-21 | — | — | EP | claimed |
| EP-4073044-B1 | NEW BRAF INHIBITORS AS PARADOX BREAKERS | HOFFMANN LA ROCHE (CH) | 2025-02-19 | — | — | EP | claimed |
| CN-119233829-A | Pharmaceutical composition for preventing, inhibiting or treating symptoms associated with pseudoallergy | 学校法人高崎健康福祉大学 | 2024-12-31 | — | — | CN | claimed |
| US-20240415819-A1 | MACROCYCLIC COMPOUNDS AS PROTEASOME SUBUNIT BETA TYPE-5 INHIBITORS | QLi5 Therapeutics AG (DE) | 2024-12-19 | — | — | US | claimed |
| CN-118851955-A | 2-Arylmethoxyiminocyclohexane sulfonamide compound, and preparation method and application thereof | 沈阳农业大学 | 2024-10-29 | — | — | CN | claimed |
| CN-118401505-A | Heterocyclic compounds as SHP2 inhibitors, compositions comprising the same, and methods of use thereof | 捷思英达控股有限公司 | 2024-07-26 | — | — | CN | claimed |
| CN-118176003-A | Medicaments comprising P2X4 receptor antagonists for the prevention or treatment of nociceptive pain and/or visceral pain | 日本化学药品株式会社 | 2024-06-11 | — | — | CN | claimed |
| CN-118019551-A | Preventive or therapeutic agent for respiratory diseases | 日本化学药品株式会社 | 2024-05-10 | — | — | CN | claimed |
| CN-117624890-A | Preparation process of flame-retardant HMMM resin for improving rubber vulcanization speed | 江苏国立化工科技有限公司 | 2024-03-01 | — | — | CN | claimed |
| US-20050054534-A1 | Substituted benzoylcyclohexane diones for use as herbicides | MULLER KLAUS-HELMUT (DE) | 2005-03-10 | — | — | US | claimed |
| EP-0906291-B1 | SUBSTITUTED PHENYL URACILS | BAYER CROPSCIENCE AG (DE) | 2005-03-09 | — | — | EP | claimed |
| EP-1244634-B1 | SUBSTITUTED BENZOYLCYCLOHEXANE DIONES FOR USE AS HERBICIDES | BAYER CROPSCIENCE AG (DE) | 2004-03-17 | — | — | EP | claimed |
| US-6245714-B1 | HERBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2001-06-12 | — | — | US | claimed |
| EP-0906291-A1 | SUBSTITUTED PHENYL URACILS | BAYER AG (DE) | 1999-04-07 | — | — | EP | claimed |
| WO-1997045418-A1 | SUBSTITUTED PHENYL URACILS | BAYER AKTIENGESELLSCHAFT (DE) | 1997-12-04 | — | — | WO | claimed |
| EP-0373951-B1 | PREPARATION OF 2,3-TRANS-1,4-BRIDGED CYCLOHEXANE SULFONAMIDE DERIVATIVES AND THEIR USE | SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. (JP) | 1993-03-24 | — | — | EP | claimed |
| US-5120865-A | PREPARATION OF 2,3-TRANS-1,4-BRIDGED CYCLOHEXANE SULFONAMIDE DERIVATIVES | SHIONOGI & CO., LTD. (JP) | 1992-06-09 | — | — | US | claimed |
| EP-0373951-A1 | Preparation of 2,3-trans-1,4-bridged cyclohexane sulfonamide derivatives and their use | SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. (JP) | 1990-06-20 | — | — | EP | claimed |
| US-4294641-A | Heat transfer sheets | REED KENNETH JAMES (GB) | 1981-10-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050054534-A1 | Substituted benzoylcyclohexane diones for use as herbicides | DDT, CYP1B1, CYP1A1 | CA1 784/4885CA2 356/4885APLNR 3654/4885 |
| US-20240415819-A1 | MACROCYCLIC COMPOUNDS AS PROTEASOME SUBUNIT BETA TYPE-5 INHIBITORS | PSMB5, PSMA5, PSMB1 | CA1 2703/4885CA2 4423/4885APLNR 4364/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.